These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 30285649)

  • 21. Imprint cytology of Gaucher's disease presenting as a splenic mass. A case report with molecular approaches.
    Kobayashi TK; Tamagaki T; Yoneyama C; Watanabe S; Sugihara H; Ida H
    Acta Cytol; 1998; 42(2):419-24. PubMed ID: 9568149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of the 55-bp deletion (c.1263del55) in exon 9 of the glucocerebrosidase gene causing misdiagnosis (for homozygous N370S (c.1226A > G) mutation) in Spanish Gaucher disease patients.
    Torralba MA; Alfonso P; Pérez-Calvo JI; Cenarro A; Pastores GM; Giraldo P; Civeira F; Pocoví M
    Blood Cells Mol Dis; 2002; 29(1):35-40. PubMed ID: 12482401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gaucher disease with prenatal onset and perinatal death due to compound heterozygosity for the missense R131C and null Rec Nci I GBA mutations.
    Goebl A; Ferrier RA; Ferreira P; Pinto-Rojas A; Matshes E; Choy FY
    Pediatr Dev Pathol; 2011; 14(3):240-3. PubMed ID: 20946052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
    Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
    J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
    Pomponio RJ; Cabrera-Salazar MA; Echeverri OY; Miller G; Barrera LA
    Mol Genet Metab; 2005 Dec; 86(4):466-72. PubMed ID: 16185907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocerebrosidase pseudogene variation and Gaucher disease: Recognizing pseudogene tracts in GBA alleles.
    Martínez-Arias R; Comas D; Mateu E; Bertranpetit J
    Hum Mutat; 2001 Mar; 17(3):191-8. PubMed ID: 11241841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.
    Theophilus B; Latham T; Grabowski GA; Smith FI
    Am J Hum Genet; 1989 Aug; 45(2):212-25. PubMed ID: 2502917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and genetic characteristics of Korean patients with Gaucher disease.
    Jeong SY; Park SJ; Kim HJ
    Blood Cells Mol Dis; 2011 Jan; 46(1):11-4. PubMed ID: 20729108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gaucher disease: A G+1----A+1 IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA.
    He GS; Grabowski GA
    Am J Hum Genet; 1992 Oct; 51(4):810-20. PubMed ID: 1415223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misdiagnosis of Niemann-Pick disease type C as Gaucher disease.
    Lo SM; McNamara J; Seashore MR; Mistry PK
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3(0 3):S429-33. PubMed ID: 20882348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory and genetic evaluation of Gaucher disease.
    Bodamer OA; Hung C
    Wien Med Wochenschr; 2010 Dec; 160(23-24):600-4. PubMed ID: 20714811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation.
    Dekker N; Voorn-Brouwer T; Verhoek M; Wennekes T; Narayan RS; Speijer D; Hollak CE; Overkleeft HS; Boot RG; Aerts JM
    Blood Cells Mol Dis; 2011 Jan; 46(1):19-26. PubMed ID: 20728381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allele frequency of a 24 bp duplication in exon 10 of the CHIT1 gene in the general Korean population and in Korean patients with Gaucher disease.
    Woo KH; Lee BH; Heo SH; Kim JM; Kim GH; Kim YM; Kim JH; Choi IH; Yang SH; Yoo HW
    J Hum Genet; 2014 May; 59(5):276-9. PubMed ID: 24621582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients.
    Grace ME; Desnick RJ; Pastores GM
    J Clin Invest; 1997 May; 99(10):2530-7. PubMed ID: 9153297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring.
    Irún P; Alfonso P; Aznarez S; Giraldo P; Pocovi M
    Clin Biochem; 2013 Dec; 46(18):1804-7. PubMed ID: 24060732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gaucher disease: importance of early diagnosis and therapy].
    Simon G; Erdos M; Maródi L; Tóth J
    Orv Hetil; 2008 Apr; 149(16):743-50. PubMed ID: 18426721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of Gaucher Disease Mutations in Parkinson Disease.
    Vilageliu L; Grinberg D
    Curr Protein Pept Sci; 2017; 18(7):758-764. PubMed ID: 26965692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two new mild homozygous mutations in Gaucher disease patients: clinical signs and biochemical analyses.
    Cormand B; Grinberg D; Gort L; Fiumara A; Barone R; Vilageliu L; Chabás A
    Am J Med Genet; 1997 Jun; 70(4):437-43. PubMed ID: 9182788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
    Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ
    Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.